← Back to catalogue
Research draft

mesothelioma

vr.tr.mesothelioma · XCT.QLT

Let an agent explain mesothelioma and its link to asbestos, relay classification, diagnosis, treatment and prognosis from oncology guidelines in general terms with attribution, describe the subtypes and stages the registry aliases name, and distinguish mesothelioma from lung cancer and pleural metastases, routing patients to clinicians and legal questions to qualified advisers.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain mesothelioma and its link to asbestos, relay classification, diagnosis, treatment and prognosis from oncology guidelines in general terms with attribution, describe the subtypes and stages the registry aliases name, and distinguish mesothelioma from lung cancer and pleural metastases, routing patients to clinicians and legal questions to qualified advisers.

A rare aggressive cancer of the mesothelium, the lining of the lungs, abdomen, heart or testes, most often malignant pleural mesothelioma, strongly linked to asbestos exposure decades earlier, classified by cell type as epithelioid, sarcomatoid or biphasic with rare variants such as desmoplastic and lymphohistiocytoid, staged from early to advanced and recurrent disease; it is a notifiable and compensable occupational disease in many countries. The model gives general information and routes people to clinicians.

What it is for: Not applicable; a disease.

It can be explain the disease; relay diagnosis and treatment; route to clinicians and advisers; distinguish related conditions.

Distinguishing features

Mesothelial origin

Asbestos related

Long latency

Occupational disease

What it looks like

Not a visible object; a tumour of the pleura or other lining.

Physical character

asbestos link: about 80 percent of cases note

latency: 20-50 years

median survival: about 12-21 months - varies by type and treatment

incidence: about 30000 cases per year - worldwide, estimates

How it is recognised

Cancer of the mesothelium

Malignant pleural mesothelioma, biphasic, desmoplastic, lymphohistiocytoid, advanced and recurrent disease

Lung cancer arises in the lung; pleural metastases come from other cancers

Related models

is a kind of - in registry terms

asbestos-related disease

is a kind of - in registry terms

notifiable disease

is caused by - in most cases

asbestos

is contrasted with - which arises in lung tissue

lung cancer

In practice

Families and kinds

pleural mesothelioma

peritoneal mesothelioma

pericardial and testicular mesothelioma

epithelioid, sarcomatoid and biphasic types

rare variants such as desmoplastic and lymphohistiocytoid

advanced and recurrent disease

Identifiers

ICD-10 C45 mesothelioma

MeSH D008654 Mesothelioma

Standards and regulation

Asbestos bans and occupational exposure limits

Occupational disease compensation schemes

Oncology guidelines such as ESMO and NCCN

Failure modes and hazards

Agents giving personal medical or legal advice

Late diagnosis

Registry aliases mixing subtypes and stages

Also called

malignant pleural mesotheliomalymphohistiocytoid mesotheliomarecurrent malignant pleural mesotheliomaadvanced malignant pleural mesotheliomapleural biphasic mesotheliomapleural desmoplastic mesotheliomapleural epithelioid mesotheliomapleural sarcomatoid mesotheliomapericardial mesotheliomamalignant mesotheliomamalignant biphasic mesotheliomasarcomatoid mesotheliomamalignant epithelial mesotheliomalocalized malignant mesotheliomamesothelioma malignant recurrent

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Understand What mesothelioma is.

Clinical.

Definition

Definition.

Definition

Definition.

  1. What is mesothelioma, and how does it differ from lung cancer and pleural metastases? definition
  2. Is the user describing personal symptoms, a diagnosis or a compensation claim, which need clinicians or qualified advisers? boundary

Types

Types.

Types

Types.

  1. What are pleural, peritoneal, epithelioid, sarcomatoid, biphasic, desmoplastic and lymphohistiocytoid mesothelioma? definition
  2. Which entry fits the specific type? action
Cause Cause and prevention.

Regulation.

Asbestos

Asbestos.

Asbestos

Asbestos.

  1. How does asbestos cause mesothelioma, and which exposures carry risk? provenance
  2. Which references are standard? provenance

Prevention

Prevention and law.

Prevention

Prevention.

  1. How do bans, exposure limits and compensation schemes address the disease? provenance
  2. Which sources are cited? provenance
Care Diagnosis and treatment.

Clinical.

Diagnosis

Diagnosis and staging.

Diagnosis

Diagnosis.

  1. How is mesothelioma diagnosed and staged, as guidelines describe? provenance
  2. Which entry fits pleural biopsy? action

Treatment

Treatment.

Treatment

Treatment.

  1. What are surgery, chemotherapy, immunotherapy and palliative options, in general terms? provenance
  2. Which entry fits the specific treatment? action
Context Epidemiology and support.

Context.

Epidemiology

Epidemiology.

Epidemiology

Epidemiology.

  1. How does incidence vary by country and over time with asbestos use? provenance
  2. Which entry fits occupational disease? action

Support

Support.

Support

Support.

  1. What patient support and research organisations exist? provenance
  2. Which entry fits cancer support organisations? action

What the second pass must settle

  • Should pleural mesothelioma and the histological subtypes be separate primary entries?
  • How should oncology and occupational health sources be linked?
  • The registry entry has merged aliases naming subtypes and stages; should they be split off?